1. Home
  2. SRDX vs VKI Comparison

SRDX vs VKI Comparison

Compare SRDX & VKI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • SRDX
  • VKI
  • Stock Information
  • Founded
  • SRDX 1979
  • VKI 1993
  • Country
  • SRDX United States
  • VKI United States
  • Employees
  • SRDX N/A
  • VKI N/A
  • Industry
  • SRDX Medical/Dental Instruments
  • VKI Finance Companies
  • Sector
  • SRDX Health Care
  • VKI Finance
  • Exchange
  • SRDX Nasdaq
  • VKI Nasdaq
  • Market Cap
  • SRDX 415.4M
  • VKI 377.0M
  • IPO Year
  • SRDX 1998
  • VKI N/A
  • Fundamental
  • Price
  • SRDX $34.15
  • VKI $8.29
  • Analyst Decision
  • SRDX Buy
  • VKI
  • Analyst Count
  • SRDX 3
  • VKI 0
  • Target Price
  • SRDX $43.00
  • VKI N/A
  • AVG Volume (30 Days)
  • SRDX 342.3K
  • VKI 112.8K
  • Earning Date
  • SRDX 08-08-2025
  • VKI 01-01-0001
  • Dividend Yield
  • SRDX N/A
  • VKI 4.52%
  • EPS Growth
  • SRDX N/A
  • VKI N/A
  • EPS
  • SRDX N/A
  • VKI N/A
  • Revenue
  • SRDX $120,801,000.00
  • VKI N/A
  • Revenue This Year
  • SRDX N/A
  • VKI N/A
  • Revenue Next Year
  • SRDX $3.38
  • VKI N/A
  • P/E Ratio
  • SRDX N/A
  • VKI N/A
  • Revenue Growth
  • SRDX N/A
  • VKI N/A
  • 52 Week Low
  • SRDX $26.00
  • VKI $7.07
  • 52 Week High
  • SRDX $40.39
  • VKI $8.98
  • Technical
  • Relative Strength Index (RSI)
  • SRDX 43.47
  • VKI 49.45
  • Support Level
  • SRDX $34.99
  • VKI $8.25
  • Resistance Level
  • SRDX $37.77
  • VKI $8.35
  • Average True Range (ATR)
  • SRDX 1.54
  • VKI 0.06
  • MACD
  • SRDX -0.54
  • VKI -0.01
  • Stochastic Oscillator
  • SRDX 3.28
  • VKI 20.00

About SRDX Surmodics Inc.

Surmodics Inc is a provider of performance coating technologies for intravascular medical devices and chemical and biological components for in vitro diagnostic (IVD) immunoassay tests and microarrays. The company's reportable segments are; Medical Device and In Vitro Diagnostics. Maximum revenue for the company is derived from its Medical Device segment which is involved in the manufacturing and licensing of performance coatings, including surface modification coating technologies and drug-delivery coating technologies. This segment also manufactures vascular intervention medical devices, including drug-coated balloons, mechanical thrombectomy devices, and radial access balloon catheters and guide sheaths. Geographically, the company derives key revenue from its domestic market.

About VKI Invesco Advantage Municipal Income Trust II of Beneficial Interest (DE)

Invesco Advantage Municipal Income Trust II is a diversified, closed-end management investment company. The investment objective of the company is to provide common shareholders with a high level of current income exempt from federal income tax, consistent with preservation of capital.

Share on Social Networks: